Following the Money: What Summit Wealth's JVAL Investment Tells Us

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

The Great Chip Gambit: Trump, Xi, and the Future of AI Supremacy

The Retail Giant Shrinks: Amazon's Staggering 30,000 Job Cut Plan

Huntington's Southern Gambit: A Banking Giant Eyes Cadence and New Horizons

A Remarkable Re-Entry: How GSK's Blenrep Battled Back for a Second Shot at Fighting Myeloma

The Unstoppable Pulse: HCA Healthcare's Surprising Triumph

Novartis' Cosentyx Shines in Long-Term Trial, Offering Hope for Chronic Joint Pain Sufferers

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal

Mattel Unleashes Iconic Worlds: Barbie, Hot Wheels, and More Zoom into the Roblox Metaverse!

Humana's Billion-Dollar Setback: Court Upholds CMS Medicare Advantage Rating Changes

Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

China's Bold Gambit: New K-Visa Program Ignites Global Talent War Amidst US H-1B Curbs

Warning Bells Ring: The Buffett Indicator Flashes 'Playing with Fire' Levels

AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing

BP Unleashes $5 Billion Deepwater Giant in Gulf of Mexico

Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File

Micron's AI Revolution: CEO Sanjay Mehrotra Declares AI the Undeniable Catalyst for Record-Breaking Growth

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid

DRC Unveils Game-Changing Cobalt Export System: A New Era for the Global Market

Billionaire David Tepper: Why He Hates This Market But Won't Challenge the Fed

A Beacon of Hope: Regeneron's Pozelimab Shines in Ultra-Rare Genetic Disorder Study

The Billionaire's Gaze: How Palantir's Valuation Inspired Marc Benioff to Rethink Salesforce's Price Tag

A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval

Equity Mutual Fund Inflows Dip 21% in August, But SIPs Soar to New High

Oracle Defies Gravity: Why Its Stock Soared After a Q1 Earnings 'Miss'

Navigating the Cosmic Currents: Planet Labs Soars, EchoStar Eyes Starlink, and AST SpaceMobile Faces Turbulence

UnitedHealthcare Expands Glaucoma Treatment Access by Covering Sight Sciences' OMNI System

PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment

Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

Europe's Staggering $3.5 Billion Fine Rocks Google, Ignites Trump's Call for American Investment

The Looming Uranium Crisis: Will Nuclear Power's Ambitions Be Derailed by 2030?

Salesforce's AI Aspirations: A Revolution or Just a Ripple?

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling